Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 2, 2026
Purchase
Shares
83,561
Price
$14.33
Total Value
$1.20M
Shares Held After
11,929,500
% of Holdings
0.7%

Beta Bionics, Inc. (BBNX)

Saint Sean — Director
Mar 2, 2026
Sale
Shares
3,384
Price
$12.36
Total Value
$41.83K
Shares Held After
437,809
% of Holdings
0.8%

Intellia Therapeutics, Inc. (NTLA)

BASTA JAMES — EVP, General Counsel
Mar 2, 2026
Sale
Shares
1,211
Price
$13.78
Total Value
$16.69K
Shares Held After
156,794
% of Holdings
0.8%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Milanova Tsveta — Chief Commercial Officer
Mar 2, 2026
Sale
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
41,591
% of Holdings
2.8%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Milanova Tsveta — Chief Commercial Officer
Mar 2, 2026
Sale
Shares
1,681
Price
$28.96
Total Value
$48.68K
Shares Held After
38,778
% of Holdings
4.2%

Alector, Inc. (ALEC)

Wong-Sarad Grace — Principal Accounting Officer
Mar 2, 2026
Sale
Shares
8,071
Price
$2.12
Total Value
$17.14K
Shares Held After
110,832
% of Holdings
6.8%

Karyopharm Therapeutics Inc. (KPTI)

Cheng Sohanya Roshan — EVP & Chief Commercial Officer
Mar 2, 2026
Sale
Shares
4,604
Price
$9.41
Total Value
$43.32K
Shares Held After
107,317
% of Holdings
4.1%

Arcutis Biotherapeutics, Inc. (ARQT)

Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Mar 2, 2026
Sale
Shares
1,987
Price
$25.70
Total Value
$51.07K
Shares Held After
136,932
% of Holdings
1.4%

Arcutis Biotherapeutics, Inc. (ARQT)

Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Mar 2, 2026
Sale
Shares
193
Price
$25.91
Total Value
$5.00K
Shares Held After
136,932
% of Holdings
0.1%

Arcutis Biotherapeutics, Inc. (ARQT)

Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Mar 2, 2026
Sale
Shares
6,553
Price
$25.16
Total Value
$164.88K
Shares Held After
137,125
% of Holdings
4.6%

Intellia Therapeutics, Inc. (NTLA)

Clark Eliana — EVP, Chief Technical Officer
Mar 2, 2026
Sale
Shares
607
Price
$13.78
Total Value
$8.36K
Shares Held After
93,864
% of Holdings
0.6%
Mar 2, 2026
Purchase
Shares
27,555
Price
$14.24
Total Value
$392.52K
Shares Held After
27,555
% of Holdings
100.0%
Mar 2, 2026
Sale
Shares
1,068
Price
$25.91
Total Value
$27.68K
Shares Held After
785,957
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
36,281
Price
$25.16
Total Value
$912.85K
Shares Held After
787,025
% of Holdings
4.4%

Karyopharm Therapeutics Inc. (KPTI)

Mano Michael — EVP, CLO&Secretary
Mar 2, 2026
Sale
Shares
3,526
Price
$9.41
Total Value
$33.18K
Shares Held After
93,964
% of Holdings
3.6%

Teladoc Health, Inc. (TDOC)

Bliss Kelly — President, U.S. Group Health
Mar 2, 2026
Sale
Shares
26,647
Price
$5.12
Total Value
$136.35K
Shares Held After
84,747
% of Holdings
23.9%
Mar 2, 2026
Sale
Shares
12,361
Price
$9.41
Total Value
$116.31K
Shares Held After
267,030
% of Holdings
4.4%

Liquidia Corp (LQDA)

Krepp Sarah — Chief Human Resource Officer
Mar 2, 2026
Sale
Shares
276
Price
$30.58
Total Value
$8.44K
Shares Held After
164,658
% of Holdings
0.2%
Mar 2, 2026
Purchase
Shares
4,300
Price
$17.90
Total Value
$76.97K
Shares Held After
9,555
% of Holdings
45.0%

Arcutis Biotherapeutics, Inc. (ARQT)

Edwards Larry Todd — Reporting Person's title: EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
103
Price
$25.91
Total Value
$2.67K
Shares Held After
175,178
% of Holdings
0.1%

Arcutis Biotherapeutics, Inc. (ARQT)

Edwards Larry Todd — Reporting Person's title: EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
3,584
Price
$25.16
Total Value
$90.18K
Shares Held After
175,281
% of Holdings
2.0%

TENET HEALTHCARE CORP (THC)

Arnst Thomas W — EVP, Chief Admin. Officer & GC
Mar 2, 2026
Sale
Shares
24,000
Price
$234.04
Total Value
$5.62M
Shares Held After
8,012
% of Holdings
75.0%

GRAIL, Inc. (GRAL)

RAGUSA ROBERT P — Director
Mar 2, 2026
Sale
Shares
1,717
Price
$51.84
Total Value
$89.01K
Shares Held After
650,525
% of Holdings
0.3%

GRAIL, Inc. (GRAL)

RAGUSA ROBERT P — Director
Mar 2, 2026
Sale
Shares
35,787
Price
$50.09
Total Value
$1.79M
Shares Held After
652,242
% of Holdings
5.2%

Karyopharm Therapeutics Inc. (KPTI)

Poulton Stuart — EVP, Chief Development Officer
Mar 2, 2026
Sale
Shares
5,101
Price
$9.41
Total Value
$48.00K
Shares Held After
94,328
% of Holdings
5.1%
Mar 2, 2026
Sale
Shares
289,024
Price
$15.82
Total Value
$4.57M
Shares Held After
1,987,330
% of Holdings
12.7%

Ultragenyx Pharmaceutical Inc. (RARE)

Huizenga Theodore Alan — SVP, Chief Accounting Officer
Mar 2, 2026
Sale
Shares
1,632
Price
$22.80
Total Value
$37.21K
Shares Held After
48,670
% of Holdings
3.2%
Mar 2, 2026
Sale
Shares
10,079
Price
$8.36
Total Value
$84.26K
Shares Held After
103,996
% of Holdings
8.8%

Teladoc Health, Inc. (TDOC)

Rodrigues Fernando M. — President of BetterHelp
Mar 2, 2026
Sale
Shares
16,314
Price
$5.12
Total Value
$83.48K
Shares Held After
25,086
% of Holdings
39.4%

Arcutis Biotherapeutics, Inc. (ARQT)

Vairavan Latha — SVP Chief Financial Officer
Mar 2, 2026
Sale
Shares
81
Price
$25.91
Total Value
$2.10K
Shares Held After
87,754
% of Holdings
0.1%

Arcutis Biotherapeutics, Inc. (ARQT)

Vairavan Latha — SVP Chief Financial Officer
Mar 2, 2026
Sale
Shares
2,772
Price
$25.16
Total Value
$69.74K
Shares Held After
87,835
% of Holdings
3.1%

Schrödinger, Inc. (SDGR)

Farid Ramy — Director
Mar 2, 2026
Sale
Shares
5,560
Price
$11.90
Total Value
$66.15K
Shares Held After
334,485
% of Holdings
1.6%

Karyopharm Therapeutics Inc. (KPTI)

Abate Kristin — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
559
Price
$9.41
Total Value
$5.26K
Shares Held After
22,063
% of Holdings
2.5%

Beta Bionics, Inc. (BBNX)

Mensinger Mike — Chief Product Officer
Mar 2, 2026
Sale
Shares
1,064
Price
$12.36
Total Value
$13.15K
Shares Held After
188,793
% of Holdings
0.6%

Beta Bionics, Inc. (BBNX)

Feider Stephen — Chief Financial Officer
Mar 2, 2026
Sale
Shares
1,428
Price
$12.36
Total Value
$17.65K
Shares Held After
172,729
% of Holdings
0.8%

CVRx, Inc. (CVRX)

Hykes Kevin — Director
Mar 2, 2026
Sale
Shares
7,763
Price
$7.90
Total Value
$61.35K
Shares Held After
284,237
% of Holdings
2.7%

American Well Corporation (AMWL)

HIRSCHHORN MARK — Chief Financial Officer
Mar 2, 2026
Sale
Shares
10,796
Price
$5.24
Total Value
$56.57K
Shares Held After
203,586
% of Holdings
5.0%

ABBOTT LABORATORIES (ABT)

Salvadori Daniel Gesua Sive — EVP AND GROUP PRESIDENT
Mar 2, 2026
Sale
Shares
885
Price
$115.58
Total Value
$102.29K
Shares Held After
146,377
% of Holdings
0.6%

Liquidia Corp (LQDA)

Boyle Dana — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
445
Price
$30.58
Total Value
$13.61K
Shares Held After
178,840
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
5,423
Price
$128.44
Total Value
$696.55K
Shares Held After
204,155
% of Holdings
2.6%
Mar 2, 2026
Sale
Shares
4,043
Price
$128.44
Total Value
$519.29K
Shares Held After
209,578
% of Holdings
1.9%
Mar 2, 2026
Sale
Shares
4,347
Price
$128.44
Total Value
$558.33K
Shares Held After
213,621
% of Holdings
2.0%

iRhythm Holdings, Inc. (IRTC)

Wilson Daniel G. — Chief Financial Officer
Mar 2, 2026
Sale
Shares
1,261
Price
$128.45
Total Value
$161.98K
Shares Held After
35,660
% of Holdings
3.4%

iRhythm Holdings, Inc. (IRTC)

Wilson Daniel G. — Chief Financial Officer
Mar 2, 2026
Sale
Shares
564
Price
$128.45
Total Value
$72.45K
Shares Held After
36,921
% of Holdings
1.5%

iRhythm Holdings, Inc. (IRTC)

Wilson Daniel G. — Chief Financial Officer
Mar 2, 2026
Sale
Shares
815
Price
$128.44
Total Value
$104.68K
Shares Held After
37,485
% of Holdings
2.1%

iRhythm Holdings, Inc. (IRTC)

Wilson Daniel G. — Chief Financial Officer
Mar 2, 2026
Sale
Shares
755
Price
$128.44
Total Value
$96.97K
Shares Held After
38,300
% of Holdings
1.9%

NovoCure Limited (NVCR)

Paravasthu Mukund — Chief Operating Officer
Mar 2, 2026
Sale
Shares
408
Price
$13.49
Total Value
$5.51K
Shares Held After
76,343
% of Holdings
0.5%

Teladoc Health, Inc. (TDOC)

Nueno Carlos — President, International
Mar 2, 2026
Sale
Shares
20,165
Price
$5.12
Total Value
$103.18K
Shares Held After
50,595
% of Holdings
28.5%
Mar 2, 2026
Sale
Shares
200
Price
$102.08
Total Value
$20.42K
Shares Held After
64,424
% of Holdings
0.3%
Mar 2, 2026
Sale
Shares
2,100
Price
$101.63
Total Value
$213.43K
Shares Held After
64,624
% of Holdings
3.1%
Version: v26.3.33